Blood pressure changes in mid-30s linked to poorer brain health
The Insight 46 study has indicated that changes in blood pressure in people as young as 36 may be linked to poorer brain health later in life.
Browsing: dementia
A first-in-human, gene-silencing treatment for Alzheimer’s disease with Catherine Mummery
Genetic therapies represent a remarkable avenue for potentially slowing and preventing neurodegenerative diseases. This includes a first-in-human, gene-silencing treatment for Alzheimer’s disease. Find out more on this from Catherine Mummery.
Translating blood biomarkers into the clinic for neurodegenerative diseases with Henrik Zetterberg
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
A blood test for early Alzheimer’s disease demonstrates 94% accuracy in diagnosis
A blood test to diagnose individuals at risk of developing Alzheimer’s disease before symptoms arise may be closer to reality, as researchers report a 94% accuracy in recent findings.
Antibody therapeutics for Alzheimer’s disease: an interview with Jeffrey Cummings
In this interview, Jeffrey Cummings speaks to us about the current landscape around antibody therapeutics for Alzheimer’s disease.
Phase II/III trials of umibecestat to discontinue for Alzheimer’s disease: industry news round-up
This week in industry we’re taking a look at the discontinuation of umibecestat and Acthar® Gel for Alzheimer’s and ALS, respectively, as well as the drug discovery shift from the amyloid approach in the Alzheimer’s field.
AAIC 2019: Why is Alzheimer’s disease more prevalent in women? Sex-specific differences reported
New studies presented at AAIC 2019 reveal that sex-specific differences could play a role in the risk, progression and resilience of Alzheimer’s disease.
AAIC 2019: Are we one step closer to finding a blood test for Alzheimer’s?
Studies presented at AAIC 2019 have revealed the significant advances being made in the global search for blood-based biomarkers for dementia.
AAIC 2019: Sleep medications may increase dementia risk depending on race and gender
Observational studies reveal that use of sleep medications can increase an individual’s chances of developing dementia in sex-specific and race-specific ways.
AAIC 2019: How can sleep disruption be improved in individuals with dementia?
Studies presented at AAIC 2019 provide potential treatment methods for the improvement of sleep quality in individuals with dementia.
